EUVIMEDDescubrir EUVIMED
Crossref

Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy

Yao Li, Xiao-Jie Ju iD, Han Fu, Chang-Hai Zhou, Yi Gao, Jun Wang, Rui Xie iD, Wei Wang iD, Zhuang Liu iD, Liang-Yin Chu iD

ACS Applied Materials & Interfaces · 2023-01-11 · 15 (1) · 638-650

DOI: 10.1021/acsami.2c19241 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, published online on 2022-12-28. Written by Yao Li and 9 co-authors. Institution: School of Chemical Engineering, Sichuan University, Chengdu610065, China. Major MEDLINE topics: Calcitonin, Osteoporosis. Cited 40 times so far (Crossref); 45 references. Funded by: Sichuan University, National Natural Science Foundation of China.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

A composite separable microneedles (MNs) system consisting of silk fibroin (SF) needle tips and hyaluronic acid (HA) base is developed for transdermal delivery of salmon calcitonin (sCT) for therapy of osteoporosis. Poly(ethylene glycol) (PEG) is used to modulate the conformation structure of SF to achieve controllable sustained release of sCT. The prepared MNs can effectively penetrate the skin stratum corneum. After application to the skin, the HA base is dissolved within 2 min, allowing these SF drug depots to be implanted into the skin for controllable sustained release of sCT. The release kinetics of sCT can be controlled by regulating the conformation of SF with PEG and the interaction between sCT peptide and SF proteins. Compared with traditional needle injection, delivery of sCT using optimized HA-PEG/SF MNs shows better trabecular bone repair for ovariectomized-induced osteoporosis in mice. The proposed MNs system provides a new noninjection strategy for therapy of osteoporosis.

Subjects

MeSH terms (MEDLINE)

CalcitoninOsteoporosisMiceAnimalsDelayed-Action PreparationsAdministration, CutaneousDrug Delivery SystemsNeedles

Author keywords

controlled-release kineticsosteoporosissalmon calcitoninseparable microneedlestransdermal delivery

Substances

salmon calcitoninDelayed-Action PreparationsCalcitonin

Authors and institutions

  • School of Chemical Engineering, Sichuan University, Chengdu610065, China.
  • School of Chemical Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu610065, China.
  • West China Hospital of Stomatology, Sichuan University, Chengdu610041, China.

ORCID profiles: Xiao-Jie Ju, Rui Xie, Wei Wang, Zhuang Liu, Liang-Yin Chu

Funding

  • Sichuan University
  • National Natural Science Foundation of China

Cite

APA

Li, Y., Ju, X. J., Fu, H., Zhou, C. H., Gao, Y., Wang, J., Xie, R., Wang, W., Liu, Z., & Chu, L. Y. (2023). Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy. ACS Applied Materials & Interfaces, 15(1), 638-650. https://doi.org/10.1021/acsami.2c19241

Vancouver

Li Y, Ju XJ, Fu H, Zhou CH, Gao Y, Wang J, et al. Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy. ACS Applied Materials & Interfaces. 2023;15(1):638-650. doi:10.1021/acsami.2c19241

BibTeX
@article{Li2023,
  author = {Li, Yao and Ju, Xiao-Jie and Fu, Han and Zhou, Chang-Hai and Gao, Yi and Wang, Jun and Xie, Rui and Wang, Wei and Liu, Zhuang and Chu, Liang-Yin},
  title = {Composite Separable Microneedles for Transdermal Delivery and Controlled Release of Salmon Calcitonin for Osteoporosis Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {638--650},
  doi = {10.1021/acsami.2c19241}
}
Start for free →